Cephalon Loses Bid For Quick Win In Marketing Suit

Law360, New York (March 28, 2011, 7:50 PM EDT) -- Cephalon Inc. lost a summary judgment bid Wednesday in a Pennsylvania class action claiming the company marketed the cancer pain management drug Actiq for off-label uses and caused third-party payors to pay hundreds of millions of dollars more for prescriptions.

Judge Petrese B. Tucker’s 25-page opinion, filed in the U.S. District Court for the Eastern District of Pennsylvania, denied Cephalon’s motion for summary judgment on the remaining state law and unjust enrichment claims of lead plaintiffs Indiana Carpenters Welfare Fund and the Pennsylvania Turnpike Commission....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

EMPLOYERS MUTUAL CASUALTY COMPANY et al v. CEPHALON, INC.


Case Number

2:07-cv-04492

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Other Statutory Actions

Judge

PETRESE B. TUCKER

Date Filed

October 25, 2007

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.